<DOC>
	<DOC>NCT01306864</DOC>
	<brief_summary>The objective of this study is to show that Hemospray is effective in achieving initial hemostasis and documenting rate of further bleed when compared to standard of care.</brief_summary>
	<brief_title>Hemostasis of Active Gastrointestinal (GI) Luminal Tract Bleeding</brief_title>
	<detailed_description />
	<mesh_term>Hemorrhage</mesh_term>
	<mesh_term>Peptic Ulcer</mesh_term>
	<mesh_term>Peptic Ulcer Hemorrhage</mesh_term>
	<mesh_term>Hemostatics</mesh_term>
	<mesh_term>Phenobarbital</mesh_term>
	<criteria>Bleeding peptic ulcer Patient is: &lt; 18 years of age Patient is unable to consent Patient is contraindicated to undergo endoscopy Patient has: coagulopathy, altered post surgical anatomy of the stomach, previously placed intrahepatic portosystemic shunt Patient is pregnant or lactating Patinet has an INR &gt; 2.5</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>Endoscopic Hemostasis</keyword>
	<keyword>Peptic Ulcer</keyword>
	<keyword>Recurrent Bleeding</keyword>
	<keyword>Injection Therapy</keyword>
	<keyword>Thermal Probe</keyword>
</DOC>